FeesSafety
Pluang+

HII reports record Q3 revenues of $3.5B, raises FY26 shipbuilding revenue guidance

Company Fundamentals
29 Oct 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
HII reports record Q3 revenues of $3.5B, raises FY26 shipbuilding revenue guidance

HII announced record third quarter revenues of $3.5 billion, a 10.8% increase from last year, driven by growth in its shipbuilding divisions. Net earnings rose to $217 million with diluted EPS of $5.48. The company secured $32.4 billion in new contract awards in Q3, raising its full-year 2026 shipbuilding revenue guidance to $10.5-$10.7 billion. HII also reaffirmed its operating margin and free cash flow outlook, highlighting strong execution and leadership in maritime autonomy technologies.

HII shares rose 6.38% to USD 297.09, with a typical hold time on Pluang of 33 days, providing context for its third quarter 2026 results. For readers following Industrials-sector US stocks, here is Pluang's market snapshot as of Oct 29, 2026 17:53 WIB: of 135 stocks, 76 advanced and 57 declined. Notable movers include INIO, down 5.07% with 100% sell order activity and a 3-day hold time, and BE, down 4.33% with 82% sell order activity and a 13-day hold time.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App